世界の壊死性腸炎市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Necrotising Enterocolitis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4044 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、壊死性腸炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ステージI、ステージII、ステージIII）、用途別市場規模（病院＆クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・壊死性腸炎の市場動向 ・企業の競争状況、市場シェア ・壊死性腸炎の種類別市場規模（ステージI、ステージII、ステージIII） ・壊死性腸炎の用途別市場規模（病院＆クリニック、診断センター） ・壊死性腸炎の北米市場規模2016-2027（アメリカ、カナダ） ・壊死性腸炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・壊死性腸炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・壊死性腸炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・壊死性腸炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Pfizer、Eli Lilly And Company、Bayer HealthCare、Becton, Dickinson And Company、Bristol-Myers Squibb Company、Medtronic） ・結論

Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). Such bowel wall destruction can lead to perforation of the intestine and spillage of stool into the infant’s abdomen, which can result in an overwhelming infection and death.
Treatment of Necrotising Enterocolitis consists primarily of supportive care including providing bowel rest by stopping enteral feeds, gastric decompression with intermittent suction, fluid repletion to correct electrolyte abnormalities and third-space losses, support for blood pressure, parenteral nutrition, and prompt antibiotic therapy.

Market Analysis and Insights: Global Necrotising Enterocolitis Market
The global Necrotising Enterocolitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotising Enterocolitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotising Enterocolitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotising Enterocolitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotising Enterocolitis market.

Global Necrotising Enterocolitis Scope and Market Size
Necrotising Enterocolitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Necrotising Enterocolitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Stage I
Stage II
Stage III

Segment by Application
Hospital & Clinic
Diagnostic Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Pfizer
Eli Lilly And Company
Bayer HealthCare
Becton, Dickinson And Company
Bristol-Myers Squibb Company
Medtronic

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotising Enterocolitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stage I
1.2.3 Stage II
1.2.4 Stage III
1.3 Market by Application
1.3.1 Global Necrotising Enterocolitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinic
1.3.3 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Necrotising Enterocolitis Market Perspective (2016-2027)
2.2 Necrotising Enterocolitis Growth Trends by Regions
2.2.1 Necrotising Enterocolitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Necrotising Enterocolitis Historic Market Share by Regions (2016-2021)
2.2.3 Necrotising Enterocolitis Forecasted Market Size by Regions (2022-2027)
2.3 Necrotising Enterocolitis Industry Dynamic
2.3.1 Necrotising Enterocolitis Market Trends
2.3.2 Necrotising Enterocolitis Market Drivers
2.3.3 Necrotising Enterocolitis Market Challenges
2.3.4 Necrotising Enterocolitis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Necrotising Enterocolitis Players by Revenue
3.1.1 Global Top Necrotising Enterocolitis Players by Revenue (2016-2021)
3.1.2 Global Necrotising Enterocolitis Revenue Market Share by Players (2016-2021)
3.2 Global Necrotising Enterocolitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Necrotising Enterocolitis Revenue
3.4 Global Necrotising Enterocolitis Market Concentration Ratio
3.4.1 Global Necrotising Enterocolitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotising Enterocolitis Revenue in 2020
3.5 Necrotising Enterocolitis Key Players Head office and Area Served
3.6 Key Players Necrotising Enterocolitis Product Solution and Service
3.7 Date of Enter into Necrotising Enterocolitis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Necrotising Enterocolitis Breakdown Data by Type
4.1 Global Necrotising Enterocolitis Historic Market Size by Type (2016-2021)
4.2 Global Necrotising Enterocolitis Forecasted Market Size by Type (2022-2027)

5 Necrotising Enterocolitis Breakdown Data by Application
5.1 Global Necrotising Enterocolitis Historic Market Size by Application (2016-2021)
5.2 Global Necrotising Enterocolitis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Necrotising Enterocolitis Market Size (2016-2027)
6.2 North America Necrotising Enterocolitis Market Size by Type
6.2.1 North America Necrotising Enterocolitis Market Size by Type (2016-2021)
6.2.2 North America Necrotising Enterocolitis Market Size by Type (2022-2027)
6.2.3 North America Necrotising Enterocolitis Market Size by Type (2016-2027)
6.3 North America Necrotising Enterocolitis Market Size by Application
6.3.1 North America Necrotising Enterocolitis Market Size by Application (2016-2021)
6.3.2 North America Necrotising Enterocolitis Market Size by Application (2022-2027)
6.3.3 North America Necrotising Enterocolitis Market Size by Application (2016-2027)
6.4 North America Necrotising Enterocolitis Market Size by Country
6.4.1 North America Necrotising Enterocolitis Market Size by Country (2016-2021)
6.4.2 North America Necrotising Enterocolitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Necrotising Enterocolitis Market Size (2016-2027)
7.2 Europe Necrotising Enterocolitis Market Size by Type
7.2.1 Europe Necrotising Enterocolitis Market Size by Type (2016-2021)
7.2.2 Europe Necrotising Enterocolitis Market Size by Type (2022-2027)
7.2.3 Europe Necrotising Enterocolitis Market Size by Type (2016-2027)
7.3 Europe Necrotising Enterocolitis Market Size by Application
7.3.1 Europe Necrotising Enterocolitis Market Size by Application (2016-2021)
7.3.2 Europe Necrotising Enterocolitis Market Size by Application (2022-2027)
7.3.3 Europe Necrotising Enterocolitis Market Size by Application (2016-2027)
7.4 Europe Necrotising Enterocolitis Market Size by Country
7.4.1 Europe Necrotising Enterocolitis Market Size by Country (2016-2021)
7.4.2 Europe Necrotising Enterocolitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Necrotising Enterocolitis Market Size (2016-2027)
8.2 Asia-Pacific Necrotising Enterocolitis Market Size by Type
8.2.1 Asia-Pacific Necrotising Enterocolitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Necrotising Enterocolitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Necrotising Enterocolitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Necrotising Enterocolitis Market Size by Application
8.3.1 Asia-Pacific Necrotising Enterocolitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Necrotising Enterocolitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Necrotising Enterocolitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Necrotising Enterocolitis Market Size by Region
8.4.1 Asia-Pacific Necrotising Enterocolitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Necrotising Enterocolitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Necrotising Enterocolitis Market Size (2016-2027)
9.2 Latin America Necrotising Enterocolitis Market Size by Type
9.2.1 Latin America Necrotising Enterocolitis Market Size by Type (2016-2021)
9.2.2 Latin America Necrotising Enterocolitis Market Size by Type (2022-2027)
9.2.3 Latin America Necrotising Enterocolitis Market Size by Type (2016-2027)
9.3 Latin America Necrotising Enterocolitis Market Size by Application
9.3.1 Latin America Necrotising Enterocolitis Market Size by Application (2016-2021)
9.3.2 Latin America Necrotising Enterocolitis Market Size by Application (2022-2027)
9.3.3 Latin America Necrotising Enterocolitis Market Size by Application (2016-2027)
9.4 Latin America Necrotising Enterocolitis Market Size by Country
9.4.1 Latin America Necrotising Enterocolitis Market Size by Country (2016-2021)
9.4.2 Latin America Necrotising Enterocolitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Necrotising Enterocolitis Market Size (2016-2027)
10.2 Middle East & Africa Necrotising Enterocolitis Market Size by Type
10.2.1 Middle East & Africa Necrotising Enterocolitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Necrotising Enterocolitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Necrotising Enterocolitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Necrotising Enterocolitis Market Size by Application
10.3.1 Middle East & Africa Necrotising Enterocolitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Necrotising Enterocolitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Necrotising Enterocolitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Necrotising Enterocolitis Market Size by Country
10.4.1 Middle East & Africa Necrotising Enterocolitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Necrotising Enterocolitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Necrotising Enterocolitis Introduction
11.1.4 GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Necrotising Enterocolitis Introduction
11.2.4 Pfizer Revenue in Necrotising Enterocolitis Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Eli Lilly And Company
11.3.1 Eli Lilly And Company Company Details
11.3.2 Eli Lilly And Company Business Overview
11.3.3 Eli Lilly And Company Necrotising Enterocolitis Introduction
11.3.4 Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2016-2021)
11.3.5 Eli Lilly And Company Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Necrotising Enterocolitis Introduction
11.4.4 Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2016-2021)
11.4.5 Bayer HealthCare Recent Development
11.5 Becton, Dickinson And Company
11.5.1 Becton, Dickinson And Company Company Details
11.5.2 Becton, Dickinson And Company Business Overview
11.5.3 Becton, Dickinson And Company Necrotising Enterocolitis Introduction
11.5.4 Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2016-2021)
11.5.5 Becton, Dickinson And Company Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Necrotising Enterocolitis Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2016-2021)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Medtronic
11.7.1 Medtronic Company Details
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Necrotising Enterocolitis Introduction
11.7.4 Medtronic Revenue in Necrotising Enterocolitis Business (2016-2021)
11.7.5 Medtronic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Necrotising Enterocolitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stage I
Table 3. Key Players of Stage II
Table 4. Key Players of Stage III
Table 5. Global Necrotising Enterocolitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Necrotising Enterocolitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Necrotising Enterocolitis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Necrotising Enterocolitis Market Share by Regions (2016-2021)
Table 9. Global Necrotising Enterocolitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Necrotising Enterocolitis Market Share by Regions (2022-2027)
Table 11. Necrotising Enterocolitis Market Trends
Table 12. Necrotising Enterocolitis Market Drivers
Table 13. Necrotising Enterocolitis Market Challenges
Table 14. Necrotising Enterocolitis Market Restraints
Table 15. Global Necrotising Enterocolitis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Necrotising Enterocolitis Market Share by Players (2016-2021)
Table 17. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotising Enterocolitis as of 2020)
Table 18. Ranking of Global Top Necrotising Enterocolitis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Necrotising Enterocolitis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Necrotising Enterocolitis Product Solution and Service
Table 22. Date of Enter into Necrotising Enterocolitis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Necrotising Enterocolitis Revenue Market Share by Type (2016-2021)
Table 26. Global Necrotising Enterocolitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Necrotising Enterocolitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Necrotising Enterocolitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Necrotising Enterocolitis Revenue Market Share by Application (2016-2021)
Table 30. Global Necrotising Enterocolitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Necrotising Enterocolitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Necrotising Enterocolitis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Necrotising Enterocolitis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Necrotising Enterocolitis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Necrotising Enterocolitis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Necrotising Enterocolitis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Necrotising Enterocolitis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Necrotising Enterocolitis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Necrotising Enterocolitis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Necrotising Enterocolitis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Necrotising Enterocolitis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Necrotising Enterocolitis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Necrotising Enterocolitis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Necrotising Enterocolitis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Necrotising Enterocolitis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Necrotising Enterocolitis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Necrotising Enterocolitis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Necrotising Enterocolitis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Necrotising Enterocolitis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Necrotising Enterocolitis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Necrotising Enterocolitis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Necrotising Enterocolitis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Necrotising Enterocolitis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Necrotising Enterocolitis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Necrotising Enterocolitis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Necrotising Enterocolitis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Necrotising Enterocolitis Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Company Details
Table 63. GlaxoSmithKline Business Overview
Table 64. GlaxoSmithKline Necrotising Enterocolitis Product
Table 65. GlaxoSmithKline Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Necrotising Enterocolitis Product
Table 70. Pfizer Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Eli Lilly And Company Company Details
Table 73. Eli Lilly And Company Business Overview
Table 74. Eli Lilly And Company Necrotising Enterocolitis Product
Table 75. Eli Lilly And Company Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 76. Eli Lilly And Company Recent Development
Table 77. Bayer HealthCare Company Details
Table 78. Bayer HealthCare Business Overview
Table 79. Bayer HealthCare Necrotising Enterocolitis Product
Table 80. Bayer HealthCare Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 81. Bayer HealthCare Recent Development
Table 82. Becton, Dickinson And Company Company Details
Table 83. Becton, Dickinson And Company Business Overview
Table 84. Becton, Dickinson And Company Necrotising Enterocolitis Product
Table 85. Becton, Dickinson And Company Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 86. Becton, Dickinson And Company Recent Development
Table 87. Bristol-Myers Squibb Company Company Details
Table 88. Bristol-Myers Squibb Company Business Overview
Table 89. Bristol-Myers Squibb Company Necrotising Enterocolitis Product
Table 90. Bristol-Myers Squibb Company Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Company Recent Development
Table 92. Medtronic Company Details
Table 93. Medtronic Business Overview
Table 94. Medtronic Necrotising Enterocolitis Product
Table 95. Medtronic Revenue in Necrotising Enterocolitis Business (2016-2021) & (US$ Million)
Table 96. Medtronic Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotising Enterocolitis Market Share by Type: 2020 VS 2027
Figure 2. Stage I Features
Figure 3. Stage II Features
Figure 4. Stage III Features
Figure 5. Global Necrotising Enterocolitis Market Share by Application: 2020 VS 2027
Figure 6. Hospital & Clinic Case Studies
Figure 7. Diagnostic Center Case Studies
Figure 8. Necrotising Enterocolitis Report Years Considered
Figure 9. Global Necrotising Enterocolitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Necrotising Enterocolitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Necrotising Enterocolitis Market Share by Regions: 2020 VS 2027
Figure 12. Global Necrotising Enterocolitis Market Share by Regions (2022-2027)
Figure 13. Global Necrotising Enterocolitis Market Share by Players in 2020
Figure 14. Global Top Necrotising Enterocolitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotising Enterocolitis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Necrotising Enterocolitis Revenue in 2020
Figure 16. Global Necrotising Enterocolitis Revenue Market Share by Type (2016-2021)
Figure 17. Global Necrotising Enterocolitis Revenue Market Share by Type (2022-2027)
Figure 18. North America Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Necrotising Enterocolitis Market Share by Type (2016-2027)
Figure 20. North America Necrotising Enterocolitis Market Share by Application (2016-2027)
Figure 21. North America Necrotising Enterocolitis Market Share by Country (2016-2027)
Figure 22. United States Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Necrotising Enterocolitis Market Share by Type (2016-2027)
Figure 26. Europe Necrotising Enterocolitis Market Share by Application (2016-2027)
Figure 27. Europe Necrotising Enterocolitis Market Share by Country (2016-2027)
Figure 28. Germany Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Necrotising Enterocolitis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Necrotising Enterocolitis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Necrotising Enterocolitis Market Share by Region (2016-2027)
Figure 38. China Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Necrotising Enterocolitis Market Share by Type (2016-2027)
Figure 46. Latin America Necrotising Enterocolitis Market Share by Application (2016-2027)
Figure 47. Latin America Necrotising Enterocolitis Market Share by Country (2016-2027)
Figure 48. Mexico Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Necrotising Enterocolitis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Necrotising Enterocolitis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Necrotising Enterocolitis Market Share by Country (2016-2027)
Figure 54. Turkey Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Necrotising Enterocolitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 59. Eli Lilly And Company Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 60. Bayer HealthCare Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 61. Becton, Dickinson And Company Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 62. Bristol-Myers Squibb Company Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 63. Medtronic Revenue Growth Rate in Necrotising Enterocolitis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---